Effect of Visual Presentation of Atherosclerotic Plaque on Modification of Arterial Hypertension One Year Postpartum in Women With a History of Adverse Pregnancy Outcomes, and Risk Customization With AI Prediction Algorithms
NCT ID: NCT06798649
Last Updated: 2025-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
318 participants
INTERVENTIONAL
2026-06-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study involves two randomized groups:
Intervention Group (Randomized): Women with APOs receiving detailed vascular imaging results.
Standard Management Group (Randomized): Women with APOs who will continue receiving standard health information without vascular imaging results.
Participants will be monitored for 12 months postpartum, focusing on blood pressure levels, cardiovascular health indicators, and lifestyle changes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI-Powered CURAᵀᴹ Application for Identifying At-Risk Pregnancies in Obstetric Management
NCT06974188
Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
NCT06920563
Cardiac Dysfunction and Remodeling in Patients With Preeclampsia
NCT04162236
Antenatal Diagnosis of Coarctations of the Aorta.
NCT03303768
Remote Fetal Monitoring in High Risk Pregnancies
NCT06822439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The GESTACOR study explores the proactive use of vascular imaging to improve cardiovascular health management in women who have experienced adverse pregnancy outcomes (APOs). This trial uniquely integrates advanced imaging techniques with traditional cardiovascular health assessments to evaluate the efficacy of visual feedback on health behaviour and management.
Methodology:
Participants are randomly assigned to two groups: one receiving detailed imaging feedback and the other receiving standard care without specific imaging results.
Vascular imaging involves state-of-the-art ultrasound techniques to detect arterial plaque, which could be indicative of heightened cardiovascular risk.
Over 12 months, participants undergo regular health assessments, including blood pressure monitoring, lipid profiling, and glucose testing, complemented by behavioural health evaluations to capture lifestyle modifications and adherence to prescribed medical regimens.
Expected Impacts:
The trial is structured to assess whether detailed feedback on vascular health can lead directly to better health outcomes through improved patient engagement and adherence to preventive measures.
Outcomes of this research may lead to new guidelines for postpartum women, particularly those with APOs, emphasizing early detection and intervention for cardiovascular risk factors.
Innovations and Advancements:
GESTA-COR is among the first studies to assess the direct impact of detailed vascular imaging feedback in a postpartum setting.
The study's design allows for the collection of significant data on the interplay between visual health information and patient-driven health management.
By focusing on a targeted female population traditionally underrepresented in cardiovascular research, GESTA-COR aims to fill a crucial gap in medical research and potential clinical practice, emphasizing gender-specific risk factors and tailored interventions. The findings could pave the way for integrated care approaches that significantly enhance long-term cardiovascular health in postpartum women.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stantard management
Women with APOs RECEIVE standard health information but NO receive detailed vascular imaging results.
No interventions assigned to this group
Intervention group - images vision
Women with APOs RECEIVE standard health information PLUS vascular imaging results.
The intervention in the GESTACOR study involves providing detailed feedback from vascular imaging to women who have experienced adverse pregnancy outcomes (APOs).
This is aimed at assessing whether such feedback can encourage the adoption of healthier lifestyles and enhance adherence to preventive treatments, thereby potentially reducing the incidence of postpartum hypertension and other cardiovascular diseases.
Components of the Intervention:
Vascular Imaging:
Women in the intervention group undergo advanced vascular imaging using ultrasound technology to detect the presence of arterial plaques vs. no information about vascular images in the standard manag group.
The images are analyzed to assess the extent of vascular health, focusing on areas typically affected by cardiovascular risks such as the carotid arteries.
Feedback Delivery:
Detailed results from the vascular imaging are provided to the participants in a comprehensible format by healthcare professionals specialized in cardiovascular health.
This feedback session includes a thorough explanation of the findings, highlighting areas of concern and potential risks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The intervention in the GESTACOR study involves providing detailed feedback from vascular imaging to women who have experienced adverse pregnancy outcomes (APOs).
This is aimed at assessing whether such feedback can encourage the adoption of healthier lifestyles and enhance adherence to preventive treatments, thereby potentially reducing the incidence of postpartum hypertension and other cardiovascular diseases.
Components of the Intervention:
Vascular Imaging:
Women in the intervention group undergo advanced vascular imaging using ultrasound technology to detect the presence of arterial plaques vs. no information about vascular images in the standard manag group.
The images are analyzed to assess the extent of vascular health, focusing on areas typically affected by cardiovascular risks such as the carotid arteries.
Feedback Delivery:
Detailed results from the vascular imaging are provided to the participants in a comprehensible format by healthcare professionals specialized in cardiovascular health.
This feedback session includes a thorough explanation of the findings, highlighting areas of concern and potential risks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of one or more adverse pregnancy outcomes (APOs) such as preeclampsia, gestational diabetes, preterm birth before 37 weeks of gestation, or intrauterine growth restriction (fetal weight below the 10th percentile).
Exclusion Criteria
* Inability to provide informed consent.
* Women who do not meet the specific APO criteria set out for the study.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maternal-Infantil Vall d´Hebron Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Goya, MD, PhD
Coordinator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GESTA-COR TRIAL
Identifier Type: OTHER
Identifier Source: secondary_id
Hospital Vall d'Hebron
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.